SNCA and Parkinson disease: Numerous studies have shown that α-synuclein accumulation and aggregation can activate neuroinflammation (76–79), in agreement with the evidence showing increased levels of tumor necrosis factor alpha (TNFα), interleukin-1β (IL-1β), and IL-6 in the brains of patients with PD (80–82).